{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:30:19Z","timestamp":1793698219822,"version":"4.5.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["arthroplastytoday.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arthroplasty Today"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.artd.2026.102134","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:33:50Z","timestamp":1787996030000},"page":"102134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preoperative Weight Loss Before Total Joint Arthroplasty Using Novel Glucagon-Like Peptide-1 Agonists"],"prefix":"10.1016","volume":"41","author":[{"given":"Michael W.","family":"Seward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmett J.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"DeNovio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian B.","family":"Beam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-1724","authenticated-orcid":false,"given":"Matthew P.","family":"Abdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.artd.2026.102134_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42836-021-00102-7","article-title":"Obesity, preoperative weight loss, and telemedicine before total joint arthroplasty: a review","volume":"4","author":"Seward","year":"2022","journal-title":"Arthroplasty"},{"key":"10.1016\/j.artd.2026.102134_bib2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.arth.2022.01.087","article-title":"Projected prevalence of obesity in primary total hip arthroplasty: how big will the problem get?","volume":"37","author":"Carender","year":"2022","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102134_bib3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.arth.2022.03.003","article-title":"Projected prevalence of obesity in primary total knee arthroplasty: how big will the problem get?","volume":"37","author":"Carender","year":"2022","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102134_bib4","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.arth.2021.06.021","article-title":"Preoperative nonsurgical weight loss interventions before total hip and knee arthroplasty: a systematic review","volume":"36","author":"Seward","year":"2021","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102134_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.artd.2026.102134_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","volume":"5","author":"Sorli","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.artd.2026.102134_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.artd.2026.102134_bib8","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.artd.2026.102134_bib9","series-title":"KFF health tracking poll May 2024: the public\u2019s use and views of GLP-1 drugs","author":"Montero","year":"2024"},{"key":"10.1016\/j.artd.2026.102134_bib10","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.RVW.23.00167","article-title":"Glucagon-like Peptide-1 agonists: what the orthopaedic surgeon needs to know","volume":"12","author":"Chan","year":"2024","journal-title":"JBJS Rev"},{"key":"10.1016\/j.artd.2026.102134_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.arth.2023.12.014","article-title":"Semaglutide and other GLP-1 agonists: a boon for the arthroplasty industry?","volume":"39","author":"Magruder","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102134_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.arth.2023.07.017","article-title":"Medical weight optimization for arthroplasty patients: a primer of emerging therapies for the joint arthroplasty surgeon","volume":"39","author":"Mayfield","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102134_bib13","first-page":"2085","article-title":"Weight loss before total knee arthroplasty was not associated with decreased postoperative risks","volume":"107","author":"Seward","year":"2025","journal-title":"Bone Joint J"},{"key":"10.1016\/j.artd.2026.102134_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2106\/JBJS.24.01110","article-title":"Weight loss before total hip arthroplasty was not associated with decreased postoperative risks","volume":"107","author":"Seward","year":"2025","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.artd.2026.102134_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1302\/0301-620X.105B5.BJJ-2022-1123.R1","article-title":"Depression and anxiety are associated with an increased risk of infection, revision, and reoperation following total hip or knee arthroplasty","volume":"105-b","author":"Harmer","year":"2023","journal-title":"Bone Joint J"},{"key":"10.1016\/j.artd.2026.102134_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.arth.2022.08.040","article-title":"Does metabolic Syndrome impact the risk of reoperation, revision, or complication after primary total knee arthroplasty?","volume":"38","author":"Ledford","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102134_bib17","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.2025.4735","article-title":"Uptake of and disparities in semaglutide and tirzepatide prescribing for obesity in the US","volume":"333","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.artd.2026.102134_bib18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.artd.2026.102134_bib19","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.arth.2023.12.002","article-title":"The impact of glucagon-like Peptide-1 agonists on hip and knee arthroplasty and perioperative considerations","volume":"39","author":"Jacofsky","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102134_bib20","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/oby.24331","article-title":"Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status","volume":"33","author":"Gasoyan","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.artd.2026.102134_bib21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2106\/JBJS.18.01136","article-title":"Preoperative weight loss for morbidly Obese patients undergoing total knee arthroplasty: determining the necessary amount","volume":"101","author":"Keeney","year":"2019","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.artd.2026.102134_bib22","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/oby.21358","article-title":"Is 5% weight loss a satisfactory criterion to define clinically significant weight loss?","volume":"23","author":"Williamson","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.artd.2026.102134_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2106\/JBJS.24.00468","article-title":"Glucagon-like Peptide-1 receptor agonists decrease medical and surgical complications in morbidly Obese patients undergoing primary TKA","volume":"107","author":"Kim","year":"2025","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.artd.2026.102134_bib24","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.arth.2024.05.079","article-title":"Decreased risk of readmission and complications with preoperative GLP-1 analog use in patients undergoing primary total joint arthroplasty","volume":"39","author":"Buddhiraju","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102134_bib25","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102134_bib26","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.2024.5003","article-title":"Preoperative GLP-1 receptor agonist use and risk of postoperative respiratory complications","volume":"331","author":"Dixit","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.artd.2026.102134_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like Peptide-1 receptor agonist use and residual gastric content before Anesthesia","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg"}],"container-title":["Arthroplasty Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344126001834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344126001834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:14:44Z","timestamp":1793697284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352344126001834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S2352344126001834"],"URL":"https:\/\/doi.org\/10.1016\/j.artd.2026.102134","relation":{},"ISSN":["2352-3441"],"issn-type":[{"value":"2352-3441","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Weight Loss Before Total Joint Arthroplasty Using Novel Glucagon-Like Peptide-1 Agonists","name":"articletitle","label":"Article Title"},{"value":"Arthroplasty Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.artd.2026.102134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.","name":"copyright","label":"Copyright"}],"article-number":"102134"}}